Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Jul 27, 2021 12:47pm
90 Views
Post# 33610657

RE:RE:RE:UP to 25% of Units Potentially Sold to Insiders

RE:RE:RE:UP to 25% of Units Potentially Sold to InsidersWe agree to disagree

To summarize your position BSW, if I understand it correctly:
  • "the science is a sham (PMX, EAA, SAMI and DIMI) - they are not inventors
  • they have no idea what they are doing
  • Kellum was hoodwinked to sign a 2 year contract and leave UofP
  • Toray and Birch Hill were hood-winked
  • Baxter was duped
  • they are completely aligned with shareholders with every financing cuz we're only talking a few million options that will probably expire worthless in 3 years"
  • etc.


Oh .... and "it's all about the "lifestyle" and those invaluable T4 earnings."

Oh...and "they couldn't have pulled off a Athelon or Cytosorb "valuation" with a little bit of effort - cuz the science doesn't measure up."

Oh.."and the sub $ 1 share price prevents any interest - and no one thought of a RS or Nasdaq listing to raise it up"


Do I have that all right?

MM



<< Previous
Bullboard Posts
Next >>